	Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol. BMJ Open Hull MA, Ow PL, Ruddock S, Brend T, Smith AF, Marshall H, Song M, Chan AT, Garrett WS, Yilmaz O, Drew DA, Collinson F, Cockbain AJ, Jones R, Loadman PM, Hall PS, Moriarty C, Cairns DA, Toogood GJ. PMID: 38030258 [PubMed - indexed for MEDLINE]
	Analysis of an Unselected Patient Cohort With Advanced Colorectal Carcinoma from a Maximum Care Center. Anticancer Res Zhang XW, Mohr J, Halama N, Koschny R. PMID: 38030166 [PubMed - indexed for MEDLINE]
	Predicting survival of patients with bone metastasis of unknown origin. Front Endocrinol (Lausanne) Ren Y, Qian S, Xu G, Cai Z, Zhang N, Wang Z. PMID: 38027105 [PubMed - indexed for MEDLINE]
	Mechanism Research and Application for Ginsenosides in the Treatment of Hepatocellular Carcinoma. Biomed Res Int Zhou N, Mao F, Cheng S. PMID: 38027042 [PubMed - indexed for MEDLINE]
	A novel metabolism-related gene signature in patients with hepatocellular carcinoma. PeerJ Ru B, Hu J, Zhang N, Wan Q. PMID: 38025761 [PubMed - indexed for MEDLINE]
	Serum protein biomarkers for HCC risk prediction in HIV/HBV co-infected people: a clinical proteomic study using mass spectrometry. Front Immunol Ke H, Yuan R, Liu H, Luo M, Hu H, Zhang E, Zhuang K, Yang Y, Yang R. PMID: 38022651 [PubMed - indexed for MEDLINE]
	The worthy role of hepatic arterial infusion chemotherapy in combination with anti-programmed cell death protein 1 monoclonal antibody immunotherapy in advanced hepatocellular carcinoma. Front Immunol Ding Y, Wang S, Qiu Z, Zhu C, Wang Y, Zhao S, Qiu W, Wang K, Lv J, Qi W. PMID: 38022559 [PubMed - indexed for MEDLINE]
	Study on the detection method of biological characteristics of hepatoma cells based on terahertz time-domain spectroscopy. Biomed Opt Express Guan H, Qiu W, Liu H, Cao Y, Tian L, Huang P, Hou D, Zhang G. PMID: 38021130 [PubMed]
	Safety and Effectiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Aged Greater versus Less Than 80 Years. Clin Interv Aging Zhang L, Hong W, Wang Z, Zheng C, Liang B, Shi H. PMID: 38020452 [PubMed - indexed for MEDLINE]
	TLR3 Gene Polymorphism in HCV Infection in the Kazakh Population of Western Kazakhstan. Asian Pac J Cancer Prev Nurlanova G, Zhumagaliyeva G, Iskakova A, Astrakhanov A, Kurmangazin M. PMID: 38019252 [PubMed - indexed for MEDLINE]
	Association of Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 Alpha Coding Variants with Hepatocellular Carcinoma Risk in the Moroccan Population: A Case-Control Study. Asian Pac J Cancer Prev Tanouti IA, Fellah H, El Fihry R, Zerrad C, Abounouh K, Tahiri M, Belkouchi A, Badre W, Pineau P, Benjelloun S, Ezzikouri S. PMID: 38019226 [PubMed - indexed for MEDLINE]
	SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma. BMC Cancer Zhang Y, Lao W, Yang K, Kong X, Li Y, Yu X, Wang X, Liu Y, Li Z, Deng Y, Nie S, Bi C, Wu C, Zhai A. PMID: 38017386 [PubMed - indexed for MEDLINE]
	Identification and validation of candidate clinical signatures of apolipoprotein L isoforms in hepatocellular carcinoma. Sci Rep Wang XK, Guo YX, Wang M, Zhang XD, Liu ZY, Wang MS, Luo K, Huang S, Li RF. PMID: 38017264 [PubMed - indexed for MEDLINE]
	Application of arterial infusion ports in hepatic arterial infusion chemotherapy and embolization for advanced hepatocellular carcinoma. Saudi Med J Han X, Zhao P, Wang X, Tan X, Zhang Y. PMID: 38016739 [PubMed - indexed for MEDLINE]
	Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3I148M risk allele. Hepatol Commun Kirchmeyer M, Gaigneaux A, Servais FA, Arslanow A, Casper M, Krawczyk M, Lammert F, Behrmann I. PMID: 38015590 [PubMed - indexed for MEDLINE]
	Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy. BMC Cancer Lu Z, Ni H, Yang X, Tan L, Zhuang H, Mo Y, Wei X, Qi L, Xiang B. PMID: 38012581 [PubMed - indexed for MEDLINE]
	EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma. Sci Rep Kocheise L, Schoenlein M, Behrends B, Joerg V, Casar C, Fruendt TW, Renné T, Heumann A, Li J, Huber S, Lohse AW, Pantel K, Riethdorf S, Wege H, Schulze K, von Felden J. PMID: 38012205 [PubMed - indexed for MEDLINE]
	Frontline resection or liver transplantation in patients with single-nodule hepatocellular carcinoma. Liver Int Liao R, Rodríguez-Perálvarez M. PMID: 38011642 [PubMed - indexed for MEDLINE]
	High-throughput intact Glycopeptide quantification strategy with targeted-MS (HTiGQs-target) reveals site-specific IgG N-glycopeptides as biomarkers for hepatic disorder diagnosis and staging. Carbohydr Polym Liu X, Fu B, Chen J, Sun Z, Zheng D, Li Z, Gu B, Zhang Y, Lu H. PMID: 38008487 [PubMed - indexed for MEDLINE]
	A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage. Sci Rep Ninomiya M, Tsuruoka M, Inoue J, Hiraoka A, Iwata T, Sano A, Sato K, Onuki M, Sawahashi S, Kuroda H, Oikawa T, Fujita M, Abe K, Katsumi T, Sato W, Igarashi G, Iino C, Endo T, Tanabe N, Numao H, Iijima K, Matsumoto T, Ohira H, Ueno Y, Masamune A. PMID: 38007597 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 67143

Page 1 of 3358



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy